SCHEMBL2745836

SCHEMBL2745836

CCC(N)(N)OCCOCCO

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
TSHR P16473 2/20 0.43
MAPK1 P28482 2/20 0.43
THRB P10828 1/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 1/20 0.43
ALDH1A1 P00352 2/20 0.42
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
CASP1 P29466 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
SLCO1B3 Q9NPD5 1/20 0.30
SLCO1B1 Q9Y6L6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9293329 0.86
Di(Hydroxyethyl)Ether SCHEMBL3315758 0.82 TSHR (0.48) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL1274280 0.82 HSD17B10 (0.30)
SCHEMBL28067036 0.77 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Triethylene Glycol SCHEMBL3214314 0.76 MEN1 (0.65) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL8587608 0.76 MEN1 (0.50) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL1006171 0.76 MEN1 (0.50) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL9322990 0.76 MEN1 (0.50) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL1003632 0.76 MEN1 (0.50) MEN1KMT2ATSHRMAPK1THRB
Triethylene Glycol SCHEMBL8587605 0.76 MEN1 (0.50) MEN1KMT2ATSHRMAPK1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12454596-B2 Two part curable compositions HENKEL AG & CO. KGAA (DE) 2025-10-28 US claimed
EP-4240193-A1 DEVICE AND METHOD FOR INTEGRATING HAIR EXTENSIONS Invisastrands LLC (US) 2023-09-13 EP claimed
US-20230220152-A1 TWO PART CURABLE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2023-07-13 US claimed
EP-4204498-A1 TWO PART CURABLE COMPOSITIONS Henkel AG & Co. KGaA (DE) 2023-07-05 EP claimed
WO-2022098376-A1 DEVICE AND METHOD FOR INTEGRATING HAIR EXTENSIONS Invisastrands LLC (US) 2022-05-12 WO claimed
US-20220132966-A1 DEVICE AND METHOD FOR INTEGRATING HAIR EXTENSIONS Invisastrands LLC (US) 2022-05-05 US claimed
US-11317668-B1 Device and method for integrating hair extensions Invisastrands LLC (US) 2022-05-03 US claimed
WO-2022046836-A1 TWO PART CURABLE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2022-03-03 WO claimed
WO-2007149377-A2 EPOXY ADHESIVE COMPOSITION AND USE THEREOF ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC (US) 2007-12-27 WO claimed
US-20070293603-A1 Epoxy adhesive composition and use thereof ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC (US) 2007-12-20 US claimed
EP-0882749-B1 Urethane prepolymer, process for producing the same and pressure-sensitive adhesive comprising the same KYOEISHA CHEMICAL CO LTD (JP) 2004-03-24 EP claimed
US-6022907-A POLYESTERURETHANE FROM DIMER ACIDS, REACTIVE END GROUPSA KYOEISHA CHEMICAL CO., LTD. (JP) 2000-02-08 US claimed
EP-0882749-A2 Urethane prepolymer, process for producing the same and pressure-sensitive adhesive comprising the same KYOEISHA CHEMICAL CO., LTD. (JP) 1998-12-09 EP claimed
US-12584049-B2 Adhesive compositions for anchoring fasteners H.B. FULLER COMPANY (US) 2026-03-24 US disclosed
US-12454596-B2 Two part curable compositions HENKEL AG & CO. KGAA (DE) 2025-10-28 US disclosed
US-20240228778-A1 ULTRA-LIGHT EPOXY COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY 2024-07-11 US disclosed
US-4229505-A WEAR LAYERS FOR FLOOR COVERINGS ARMSTRONG CORK COMPANY (US) 1980-10-21 US disclosed
US-4221902-A CROSSLINKED, WEAR LAYER COATINGS ARMSTRONG CORK COMPANY (US) 1980-09-09 US disclosed
US-4218515-A FOR FLOOR COVERINGS HECKLES JOHN S 1980-08-19 US disclosed
US-4217439-A CROSSLINKED DIACRYLATE-DIACETOACETAMIDE POLYMER ARMSTRONG CORK COMPANY (US) 1980-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12584049-B2 Adhesive compositions for anchoring fasteners ITGA1, ACTN1, ITGB1 MEN1 3711/4885KMT2A 2044/4885TSHR 1988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.